Market Intelligence
Biotech Market Charts
20 interactive charts tracking market trends, funding cycles, pipeline analytics, and proprietary indicators for the global biotech industry.
Market Overview
Biotech Total Market Cap Index
Total market capitalization of all tracked public biotech companies
Small & Mid-Cap Biotech Index
Market cap excluding the top 50 largest companies — the real health of the broader market
Sector Market Cap Weight
Each sector's weight relative to total biotech market cap
Geographic Market Distribution
Market cap share by country — where biotech capital concentrates
Public Biotech Companies Tracked
Number of publicly listed biotech companies with active stock data
Funding & Capital Cycles
Biotech Funding Volume
Total funding raised by biotech companies per month
Funding Round Type Distribution
Mix of round types (Seed, Series A-C, IPO, Grant) over time
IPO Activity Index
Number of biotech IPOs and public offerings per quarter
Average & Median Round Size
How funding round sizes are trending over time
Pipeline & Clinical Intelligence
Clinical Trial Starts by Phase
New trials initiated per quarter, grouped by clinical phase
Pipeline Stage Distribution
Current snapshot — how many drugs at each development stage
FDA Novel Drug Approvals
New drugs and biologics (NDA + BLA) approved per quarter — excludes generics
FDA Decision Calendar Density
Upcoming FDA decisions per month — where regulatory volatility clusters
Sector Performance
Sector Performance Scoreboard
30-day performance ranking of all biotech sectors
Sector Market Cap Trends
How sector market caps are evolving — reveals capital rotation
BiotechTube Indicators
PROBiotechTube Hype IndexPRO
Momentum-based sentiment gauge: 0 (extreme fear) to 100 (euphoria)
Pipeline Value RatioPRO
Phase 3 drugs per $B of market cap — which sectors have untapped pipeline value
Funding Velocity IndicatorPRO
90-day vs 365-day funding moving average — signals funding cycle direction
Biotech Trading Volume IndexPRO
Aggregate daily trading volume across tracked public biotech companies